Uroguanylin Topoisomer A (human)

Description:

N/A

Sequence:

NDDCELCVNVACTGCL (Disulfide bridge: 4 - 12, 7 - 15)

General

References

Comments (0)

Name	Uroguanylin Topoisomer A (human)
Category	Guanylin and Uroguanylin
One Letter Code	NDDCELCVNVACTGCL (Disulfide bridge: 4 - 12, 7 - 15)
Three Letter Code	{Asn}{Asp}{Asp}{Cys}{Glu}{Leu}{Cys}{Val}{Asn}{Val}{Ala}{Cys}{Thr}{Gly}{Cys}{Leu} (Disulfide bridge: 4-12, 7-15) (Disulfide bridge: 4 - 12, 7 - 15)
Molecular Weight	1667.880
Application	Gastrointestinal ResearchObesity Research

Taxt, Arne M., et al. "Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin." Infection and immunity 82.7 (2014): 2913-2922.

Qian, Xun, et al. "The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor)." American Journal of Physiology-Renal Physiology 300.2 (2011): F561-F573.

Silos-Santiago, Inmaculada, et al. "Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation." PAIN® 154.9 (2013): 1820-1830.

Seeley, Randy J., and Matthias H. Tschöp. "Uroguanylin: how the gut got another satiety hormone." The Journal of clinical investigation 121.9 (2011): 3384-3386.